WO2023037247 - COMPOSITIONS COMPRISING BACILLUS AMYLOLIQUEFACIENS FOR PREVENTING AND TREATING ULCERATIVE COLITIS
National phase entry:
Publication Number
WO/2023/037247
Publication Date
16.03.2023
International Application No.
PCT/IB2022/058383
International Filing Date
06.09.2022
Title **
[English]
COMPOSITIONS COMPRISING BACILLUS AMYLOLIQUEFACIENS FOR PREVENTING AND TREATING ULCERATIVE COLITIS
[French]
COMPOSITIONS COMPRENANT BACILLUS AMYLOLIQUEFACIENS POUR LA PRÉVENTION ET LE TRAITEMENT DE LA RECTOCOLITE HÉMORRAGIQUE
Applicants **
ARTUGEN THERAPEUTICS LTD.
Inventors
FARQUHAR, Ronald
ACTON, Susan L.
CHESNEL, Laurent
Priority Data
63/241,439
07.09.2021
US
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
EPO
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 3637 | |
| EPO | Filing, Examination, Granting | 33041 | |
| Japan | Filing, Examination, Granting | 3399 | |
| South Korea | Filing, Examination, Granting | 4435 | |
| USA | Filing, Examination, Granting | 12140 |
Total:
56,652
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Contact Us
Abstract[English]
bacteria identified as ART24 to a subject suffering from or at risk for ulcerative colitis.[French]
identifiées comme ART24 à un sujet souffrant de rectocolite hémorragique ou présentant un risque de rectocolite hémorragique.